製品の概要

  • 製品名Anti-BCL9L antibody
  • 製品の詳細
    Rabbit polyclonal to BCL9L
  • 特異性ab113110 is predicted to not cross-react with other BCL family members. At least four isoforms of BCL9L are known to exist; ab113110 will detect all four.
  • アプリケーション適用あり: ICC, WBmore details
  • 種交差性
    交差種: Human
    交差が予測される動物種: Mouse, Rat
  • 免疫原

    Synthetic peptide containing a 20 amino acid sequence from the N terminal region of Human BCL9L (NP_872363).

  • ポジティブ・コントロール
    • HeLa cell lysate.

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Store at 4°C (stable for up to 12 months).
  • バッファーPreservative: 0.02% Sodium azide
    Constituent: 99.98% PBS
  • Concentration information loading...
  • 精製度Immunogen affinity purified
  • 特記事項(精製)ab113110 is purified by affinity chromatography via a peptide column.
  • ポリ/モノポリクローナル
  • アイソタイプIgG

関連製品

アプリケーション

Our Abpromise guarantee covers the use of ab113110 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
ICC Use a concentration of 10 µg/ml.
WB Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 157 kDa.

ターゲット情報

  • 機能Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1.
  • 組織特異性Expressed in breast, ductal and invasive ductal carcinomas of the breast, sporadic colorectal adenomas and carcinomas (at protein level). Expressed in fetal brain. Expressed in lung, amygdala, eye, prostate, pancreatic and prostate cancers, head and neck tumors and embryonal tumor.
  • 配列類似性Belongs to the BCL9 family.
  • ドメインTne C-terminal domain is important for its transactivation activity.
  • 細胞内局在Nucleus.
  • Information by UniProt
  • 参照データベース
  • 別名
    • B-cell CLL antibody
    • B-cell CLL/lymphoma 9-like protein antibody
    • B-cell lymphoma 9-like protein antibody
    • B9L antibody
    • BCL9-2 antibody
    • BCL9-like protein antibody
    • BCL9-related beta-catenin-binding protein antibody
    • Bcl9l antibody
    • BCL9L_HUMAN antibody
    • DLNB11 antibody
    • Nuclear co factor of beta catenin signalling antibody
    • Protein BCL9-2 antibody
    see all

Anti-BCL9L antibody 画像

  • All lanes : Anti-BCL9L antibody (ab113110) at 1 µg/ml

    Lane 1 : HeLa cell lysate
    Lane 2 : HeLa cell lysate with Blocking peptide


    Predicted band size : 157 kDa
  • Immunocytochemistry of Bcl9L in HeLa cells with ab113110 at 10 ug/mL.

Anti-BCL9L antibody (ab113110) 使用論文

ab113110 has not yet been referenced specifically in any publications.

Product Wall

Application Western blot
Sample Mouse Cell lysate - whole cell (4T1 - mouse breast cancer cell line)
Gel Running Conditions Reduced Denaturing (4-12%)
Loading amount 30 µg
Specification 4T1 - mouse breast cancer cell line
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 23°C
Username

Abcam user community

Verified customer

投稿 May 12 2016

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"